SOHO 3rd Italian Conference

 

SOHO 3rd Italian Conference
F

SOHO Italy 2021: Hematologic Neoplasia and COVID-19

By SOHO 3rd Italian Conference FEATURING Francesco Passamonti
By SOHO 3rd Italian Conference FEATURING Francesco Passamonti
0 views
January 12, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Featured Video

11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba
Videos
18:01
SOHO 3rd Italian Conference

SOHO Italy 2021 Updates in Pathogenesis and Treatment of Therapy-Rel…

Feat. M. Teresa Voso
11:53
SOHO 3rd Italian Conference

SOHO Italy 2021: Potential New Therapeutic Approaches for Myelofibro…

Feat. S. Verstovsek
10:57
SOHO 3rd Italian Conference

SOHO Italy 2021: Biomarkers as Diagnostic Pathways in Rare Hematolog…

Feat. R. Stadler
16:13
SOHO 3rd Italian Conference

SOHO Italy 2021: BPDCN Management at MD Anderson Cancer Center

Feat. N. Pemmaraju
11:35
SOHO 3rd Italian Conference

SOHO Italy 2021: Treatment Options for Patients With BPDCN

Feat. N. Pemmaraju
17:15
SOHO 3rd Italian Conference

SOHO Italy 2021: Hematologic Neoplasia and COVID-19

Feat. F. Passamonti
10:05
SOHO 3rd Italian Conference

SOHO Italy 2021: Systemic Mastocytosis Treatment

Feat. C. Papayannidis
10:31
SOHO 3rd Italian Conference

SOHO Italy 2021 on Digital Technologies in Cancer Medicine: What to …

Feat. A. Mosquera Orgueira
14:09
SOHO 3rd Italian Conference

SOHO Italy 2021 on Machine Learning Applications in Malignant Hemato…

Feat. A. Mosquera Orgueira
13:41
SOHO 3rd Italian Conference

SOHO Italy 2021: CAR T Activities and Vision in the Context of Allia…

Feat. M. Mazza
17:52
SOHO 3rd Italian Conference

SOHO Italy 2021 Learnings From Italian Researchers About the COVID-1…

Feat. G. Martinelli
15:27
SOHO 3rd Italian Conference

SOHO Italy 2021 on Therapeutic Anti-CD38 Antibodies: The Intricate W…

Feat. F. Malavasi
19:41
SOHO 3rd Italian Conference

SOHO Italy 2021: From the Development of CAR T to Hospital Exemption…

Feat. M. Juan Otero